WB: Patients With CLL With Co-Occurring T2D Face Increase in Mortality
A significant subgroup of patients with both T2D and chronic lymphocytic leukemia (CLL) have unmet...
Read More
Ad Code: Scemblix - Leukemia - JUL Display Banners HCP Wallboard Extension - 56981
WB: Primary Allo-HCT Not Linked With Superior Overall Survival Vs. Consolidation Chemo
In patients aged 60 or younger with intermediate-risk AML, primary allogeneic HCT during first complete remission was not linked with superior overall survival, compared with consolidation chemotherapy during the first complete...
Read MoreWB: Some Older Patients With AML May Benefit From Allogeneic Stem Cell Transplantation
Subsets of patients older than 65 with AML benefit from allogeneic stem cell transplantation and intensive chemotherapy (IT), according to a study published in Hematology. Karin Mayer, MD, and colleagues conducted a...
Read More